The aim of this study was to assess whether atipamezole can restrain telazol/xylazine induced expression of c-fos in the rat brain. Rats were injected with a mixture of 13.81 mg/kg telazol and 5.21 mg/kg xylazine, following 10 min later 0.522 mg/kg atipamezole. Thereon, the thalamencephal and cerebral cortex were removed one hour after the last injection. The level of Fos protein was measured in the brain tissue by Westernblot. The results revealed that atipamezole attenuates telazol/xylazine induction of c-fos expression in the thalamencephal and cerebral cortex. The results indicated that atipamezole is able to inhibit telazol/xylazine-induced c-fos expression in the rat brain, thus protecting it from nerve damage.
INTRODUCTION
Xylazine is an α 2 -adrenergic receptor agonist. It contributes short duration analgesia, sedation, and muscle relaxation. Telazol contains a 1:1 combination of tiletamine and zolazepam. Tiletamine is a dissociative agent that produces analgesia, immobilization, and with increasing dose general anesthesia. Zolazepam is a benzodiazepine with anxiolytic and muscle relaxant properties. Advantages of telazol include a high therapeutic index, minimal respiratory effects, and a good cardiovascular support [1] . Hence, telazol as a sole immobilizing agent and in combination with xylazine is used to immobilize wildlife [2] [3] [4] , cats [5] , dogs [6] , and livestock [7, 8] . Telazol-xylazine has been used on several animal species including white-tailed deer [9] , bighorn sheep [10] , grizzly bears [11] , raccoons [12] , American martens [13] , and martes pennanti [14] . Atipamezole is a potent and selective α 2 -adrenoceptor agonist with a competitive nature which can antagonize ketamine [15] , reverse xylazine-ketamine anaesthesia in the Northern chamois [16] , reverse medetomidine -ketamine and tiletamine-zolazepam restrained fi shers [17, 18] .
Anesthesia reduces nerve cell metabolism in the central nervous system (CNS) resulting in nerve cell damage. Thus a reasonable use of a narcotic antagonist to awake the anesthetized animal may protect nerve cells. The c-fos is a member of the immediate early gene family. C-fos expresses the Fos protein which dimerizes with the Jun protein to form the activator protein-1(AP-1). AP-1 acts as a transcriptional factor binding to DNA thereby regulating the expression of nearby promoters. C-fos activation has been proposed as a marker of neuronal injury since its induction is promoted by abnormal brain function, including neuronal plasticity and delayed neuronal death [19, 20] . The c-fos expression studies have given evidence that c-fos expresses Fos protein rapidly and transiently within neurons after many types of stimulation, such as physiological stimuli, chemical agents and transmitter agonists [19, 21] . It has been proposed that c-fos may function as a third messenger in an intracellular cascade linking extracellular stimuli to long-term adaptive processes [19, 22] . C-fos gene expression is rapidly and transiently induced in many cell types for signaling late-response genes that generate functional proteins [19, 23] .
The purpose of this experiment was to determine, by using c-fos Western blot as a dependent variable, whether a selective antagonist such as atipamezole can restrain telazol-xylazine induced expression of c-fos in the brain.
MATERIALS AND METHODS

Reagents and instruments
Atipamezole (Antisedan, Orion Corporation Farmos Turku, Finland), xylazine (Bayer Co., Germany), telazol ® (100 mg/mL, Fort Dodge Animal Health, Fort Dodge, IA, USA), rabbit anti-rat polyantibody and goat anti-rat IgG (Sigma, USA), radioimmunoprecipitation assay Lysis Buffer, BeyoECL Plus and bicinchoninic acid were purchased from China. All the other chemical reagents used were of the highest grade commercially available in China. The protein electrophoresis system (Baygene Co., China), ChampGel picture processing system (Sagecreation Co., China).
Animals and grouping
Twenty male and female Sprague-Dawley rats weighing approximately 180-200g were used in the experiment. The experimental procedures were performed in accordance with the Jilin province Committee for Animal Experiments. The animals were housed at a controlled temperature (20±2℃) and maintained under light-dark cycles, each consisting of 12 h of light and 12 h of darkness (lights on from 06:00 to 18:00 h), with food and water made available ad libitum. In order to minimize stress-induced changes in c-fos expression in subsequent experiments the rats were handled (the lower abdomen was pierced with an injection needle, but no injection) for more than 5 days. The sixth day, the rats were injected with drugs. Rats were divided into four groups: 50% Dimethyl Sulphoxide (DMSO) administrated group as the control, telazol administrated group, telazol/xylazine administrated group, atipamezole-telazol/ xylazine administrated group (n=5 in each group).
Sampling procedure
Rats were given 50% DMSO in the control group. Each rat was given the mixture of 13.81 mg/kg telazol and 5.21 mg/kg xylazine followed 10 min later by 0.522 mg/ kg atipamezole intraperitoneal injection in the experiment group. About 1 h later, the rats were decapitated, the cerebral cortex and thalamencephal were dissected on ice and frozen, and stored overnight at -70°C. Total proteins were extracted with radioimmunoprecipitation assay in lysate buffer. The concentration was determined with the bicinchoninic acid kit.
Western blot
The method was referred by Niles and Smith [24] , and slightly modifi ed. Protein samples were diluted (1:4) with sample buffer (Beyotime Biotechnology) and boiled at 100 °C for 5min. protein samples (20 mg) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (5% stacking gel, 12% separating gel), electrifi ed 2.5 h at 80-120 V. The gel was equilibrated in transfer buffer (pH 8.3; 25 mM Tris/20% methanol/20 mM glycine), separated proteins were transferred 170 min at 150 mA to polyvinylidene difl uoride membranes. Subsequently, non-specifi c binding sites were blocked by incubation with 5% (w/v) non-fat dry milk freshly prepared in Tris-buffered saline containing 0.05% (v/v) 140 Tween-20 (TBST) for 2h at room temperature. polyvinylidene difl uoride membranes were then incubated with a similar solution containing a primary rabbit anti-c-Fos antibody overnight at 4 °C. After three washes with TBST, the membranes were incubated with horseradish peroxidase (HRP) -conjugated goat anti-rabbit IgG for 1 h. After washing four times in TBST, the signals were visualized using enhanced chemiluminescence (ECL) for 1 min, and then exposed to ECL hyperfi lm in the dark for periods ranging from 20s to 1.5 min. The fi lm was washed and band intensities measured by densitometry. Optical density values of Fos protein was divided by the protein concentrations of β-action. Subsequently, data were converted to percentage values.
Statistical analysis
All the experiments were repeated for 5 times. Results were presented as mean ± s. One-way ANOVA was used for group comparison, P<0.05 was considered to be signifi cant and P<0.01 was considered to be extremely signifi cant. Fig. 1 and Fig. 2 , intrabdominal cavity administration of telazol (13.81 mg/kg) /xylazine (5.21 mg/kg) caused an extremely signifi cant induction of c-fos expression in the thalamencephal and cerebral cortex of rats during the period of anesthesia, compared with the control group (P<0.01). The administration of atipamezole (0.522 mg/kg) caused an extremely signifi cant attenuation of telazol/ xylazine induction of c-fos expression in the same brain regions (P<0.01). The results showed that not only atipamezole may wake up rats anesthetized by telazol/xylazine, but can also inhibit c-fos gene expression in the rat brain.
RESULTS
As shown in
DISCUSSION
Telazol is a fi xed-ratio combination of zolazepam with tiletamine, used for injection anesthesia in dogs, cats, wild and zoo animals [25] . Tiletamine is a dissociative anesthetic similar to ketamine and phencyclidine, and zolazepam is a diazepine derivative tranquilizer used to minimize the muscle hypertonicity and seizures associated with tiletamine [26] . Xylazine has been used as a component of a variety of anaesthetics in domestic and wild animals in developing countries [27, 28] , xylazine was also a better option for premedication in dogs during a prolonged surgical intervention [29] . Telazol-xylazine has been used for injection anesthesia in several animal species. In the past some researchs have also reported that, after 1 h of urethane anesthesia, Fos-ir neurons were found in 12 nuclei in the CNS [30] . The α-Chloralose, halothane and sodium pentobarbital have induced Fos expression in the brain [1, 31] . The haloperidol increased c-fos expression in the striatum [32] . The experiment indicated that the telazol/xylazine inducted c-fos gene excessive expression in the thalamencephal and cerebral cortex. Over-expressing c-fos gene has been promoted as a marker of neuronal injury [14] . However, during the course of telazol/xylazine anesthesia, rat brain injury may be possible. So it is necessary to inject an appropriate antagonist at the appropriate time to terminate telazol/xylazine anaesthesia and inhibit the telazol/xylazine induced expression of Fos.
Atipamezole is an α 2 -adrenoceptor antagonist with an imidazole structure as synthesized by Orion Pharma Ltd., Turku, Finland [20] . It has no species-specifi c differences in its effects [23] . In the study of central nervous system functions, atipamezole provides a highly specifi c, selective and potent tool for blocking central α 2 -adrenoceptors. In veterinary practice, atipamezole has proved useful in rapidly reversing anesthesia, immobilization and undesirable side effects induced by α 2 -adrenoceptor agonists alone or in combination with other anesthetics [33] . Additionally, atipamezole-precipitated clonidine withdrawal can induce c-fos expression in rat CNS [34] . The experiment found that administration of atipamezole not only could wake up rats anesthetized with telazol/xylazine, but is also able to inhibit telazol/xylazine-induced c-fos expression in the rat thalamencephal and cerebral cortex. Thus, atipamezole may reduce neuronal injury induced by anesthesia with telazol/xylazine.
The study found that the telazol/xylazine induced the expression of c-fos in the rat thalamencephal and cerebral cortex. Atipamezole may wake up rats anesthetized with telazol/xylazine, and is able to inhibit telazol/xylazine-induced c-fos expression in the thalamencephal and cerebral cortex, thus playing a protective role in neuronal injury.
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